Study of CAR T-Cell therapy trial in India, in leukaemia patients, shows 73% response rate

Study of CAR T-Cell therapy trial in India, in leukaemia patients, shows 73% response rate

The clinical trials were conducted by researchers from IIT Bombay and Tata Memorial Hospital, Mumbai; the therapy approved in India, has been shown to be a cost-effective alternative to existing treatments for leukaemia The clinical trials were conducted by researchers from IIT Bombay and Tata Memorial Hospital, Mumbai; the therapy approved in India, has been shown to be a cost-effective alternative to existing treatments for leukaemia Health Health News, Wellbeing Tips, Diseases, Treatment and Nutrition | The Hindu

Leave a Reply

Your email address will not be published. Required fields are marked *